完整腹主动脉瘤EVAR术后1年死亡术前预测模型的验证
本研究基于SVS VQI数据库2011-2015年完整EVAR病例,随机分为训练集(n=17,836)和验证集(n=2500),构建并内部验证了预测术后1年死亡的术前模型。模型区分度良好(验证集AUC 0.724),可识别获益可能性低的高危患者。
要点
- 验证集AUC为0.724,校准良好,模型可预测EVAR术后1年死亡风险。
- 约27.5%患者有≥4个危险因素,预测1年死亡风险10%-22%,其中33.2%动脉瘤直径低于指南推荐阈值。
- 模型有助于筛选高危患者,结合预测年破裂风险判断EVAR适宜性。
核心结论
- 该验证的术前预测模型可识别EVAR术后1年死亡风险高、获益可能性低的患者。
研究设计与样本
- 基于SVS VQI 2011-2015年完整EVAR病例,随机分为训练集(n=17,836)和验证集(n=2500),候选预测因子31个。
- 采用 logistic 回归建模,逐步变量消除筛选预测因子,惩罚最大似然估计校正过拟合,并通过 bootstrap 内部验证。
主要发现
- 择期EVAR术后1年死亡率为5.5%(n=900/16,411),非择期(症状性、完整)为11.4%(n=162/1,425)。
- 显著术前预测因子包括COPD、年龄、肾功不全(肌酐≥1.8 mg/dL或透析)、射血分数<50%、转运状态、BMI<24 kg/m²、术前β受体阻滞剂暴露、较大AAA直径、较低入院血红蛋白;术前他汀使用具保护作用。
- 偏差校正AUC为0.759(Hosmer-Lemeshow拟合优度P=0.36;校准截距-0.003,斜率0.999)。
- 验证集AUC为0.724(95%CI 0.676-0.768;校准截距0.0009,斜率0.970)。
临床怎么用
- 可利用该模型评估高危患者EVAR术后1年死亡概率,结合预测年破裂风险判断手术适宜性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Most would agree that at least 1-year survival is necessary after intact abdominal aortic aneurysm (AAA) repair to appropriately justify the cost and risk of the procedure. No validated clinical decision instruments exist to predict survival after endovascular aneurysm repair (EVAR) beyond the perioperative period. The purpose of this analysis was to create a preoperative prediction model for 1-year mortality after EVAR for intact AAA in the Society for Vascular Surgery Vascular Quality Initiative. METHODS: All intact EVARs in the Society for Vascular Surgery Vascular Quality Initiative from 2011 to 2015 were randomly divided into training (n = 17,836) and validation (n = 2500) data sets, and 31 preoperative candidate predictors were identified. A logistic regression model for 1-year mortality was created, and bootstrapped stepwise variable elimination was used to reduce this model to a best subset of predictors. Penalized maximum likelihood estimation was used to correct for potential overfitting. The final model was internally validated by bootstrapping the area under the curve (AUC) and the calibration slope and intercept, and its performance when applied to the training and validation data sets was compared. RESULTS: After elective and nonelective (symptomatic, intact) EVAR, 1-year mortality was 5.5% (n = 900/16,411) and 11.4% (n = 162/1425), respectively. The mean probability of 1-year mortality was 6.0% (n = 1062) in the training set and 5.7% (n = 143) in the validation cohort (P = .12). Significant preoperative predictors of 1-year mortality included chronic obstructive pulmonary disease, age, preoperative renal insufficiency (creatinine concentration ≥1.8 mg/dL or on hemodialysis), ejection fraction <50%, transfer status, body mass index <24 kg/m2, preoperative beta-blocker exposure, larger AAA diameter, and lower admission hemoglobin level. Preoperative statin use was found to be protective. The bias-corrected AUC was 0.759 (Hosmer-Lemeshow goodness-of-fit P value of 0.36; calibration intercept, -0.003; slope, 0.999). When applied to the validation data set, the model had AUC of 0.724 (95% confidence interval, 0.676-0.768; calibration intercept, 0.0009; slope, 0.970), which was in excellent agreement with the original data set bias-corrected AUC. Notably, ∼27.5% (n = 4902) had four or more risk factors with a predicted 1-year post-EVAR mortality risk of 10% to 22% despite that 33.2% of these patients had AAA diameters below recommended treatment guideline minimum thresholds. CONCLUSIONS: This validated preoperative prediction model for 1-year mortality identifies patients less likely to benefit from EVAR. Appropriateness of intact AAA EVAR care delivery can be improved by use of this clinical decision aid to determine which high-risk patients have lower probability of mortality within the first postoperative year relative to their predicted annualized rupture risk.
引用
- Neal D, Beck AW, Eslami M, et al. Validation of a preoperative prediction model for mortality within 1 year after endovascular aortic aneurysm repair of intact aneurysms. J Vasc Surg. 2019. PMID: 30922759. doi:10.1016/j.jvs.2018.10.122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。